MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Payables (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) recorded Payables of $2.05 million in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, MapLight Therapeutics reported Payables of $3.29 million, up 72.0% from FY2024.

  • Across earlier years, Payables came in at $1.91 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly Payables since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 18.17 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 34.43 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 22.89 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 934.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 4.07 Bn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - 2.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05 Mn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 2.45 Mn
Dec 31, 2024 1.91 Mn
API Access

MapLight Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=MPLT&period=max&api_key=YOUR_API_KEY